Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter

The Parent’s Guide to Cord Blood Foundation®’s monthly newsletter reports on research and development of medical treatments using blood and tissues from human umbilical cords in language that is accessible to parents of children receiving or considering such treatments. The June 14 issue of the newsletter features a graphical presentation of stem cell biotechnology company

Asymmetrex Awarded Grant from ARMI BioFabUSA to Develop Tissue Stem Cell Counting Technology for Cell Biomanufacturing

Asymmetrex Awarded Grant from ARMI BioFabUSA to Develop Tissue Stem Cell Counting Technology for Cell Biomanufacturing

Stem cell biotechnology company Asymmetrex has been awarded a Technical Project grant from Advanced Regenerative Manufacturing Institute (ARMI) BioFabUSA. The new grant supports studies by Asymmetrex to evaluate its kinetic stem cell (KSC) counting technology as a method for determining a long-needed critical quality attribute for the biomanufacturing of potent therapeutic tissue stem cell-based products.

Asymmetrex Interviewed by SuperbCrew About New Web Portal With Tools for Therapeutic Stem Cell Applications

Asymmetrex Interviewed by SuperbCrew About New Web Portal With Tools for Therapeutic Stem Cell Applications

Last week on June 21 with the start of its participation in the virtual 2021 Annual Meeting of the International Society for Stem Cell Research, stem cell biotechnology company Asymmetrex launched a new web portal that provides scientists free online access to calculators for important parameters used in human tissue cell research.  In a June 30 post, business and technology news platform SuperbCrew interviewed Asymmetrex’s

Asymmetrex Introduces Therapeutic Stem Cell Dosage Technologies to Biotherapeutics Bioprocessing Companies New

Asymmetrex Introduces Therapeutic Stem Cell Dosage Technologies to Biotherapeutics Bioprocessing Companies

Today, May 20, in the virtual 5th Annual MarketsandMarkets Bioprocessing of Biotherapeutics Conference, the President and CEO of stem cell biotechnology company Asymmetrex, James L. Sherley, M.D., Ph.D., introduced company executives and scientists to new technologies for determining the dosage of therapeutic stem cell products and treatments. A Gold Sponsor for the conference, Asymmetrex’s kinetic

Asymmetrex Presents the Value of Tissue Stem Cell Counting For Supplying Stem Cell Clinical Trials and Drug Development Clinical Trials

Asymmetrex Presents the Value of Tissue Stem Cell Counting For Supplying Stem Cell Clinical Trials and Drug Development Clinical Trials

On September 30, stem cell biotechnology company Asymmetrex presented at the 2020 Outsourcing in Clinical Trials USA Virtual Conference. In addition to discussing the value of tissue stem cell counting for better practices in stem cell and gene therapy clinical trials, Asymmetrex director James Sherley also highlighted value that stem cell counting technologies can impart

New Report Begins a New Era of Stem Cell Science and Medicine: Stem Cell Biotechnology Company Asymmetrex Tells How It Counts Therapeutic Tissue Stem Cells

New Report Begins a New Era of Stem Cell Science and Medicine: Stem Cell Biotechnology Company Asymmetrex Tells How It Counts Therapeutic Tissue Stem Cells

In an August 28 special issue of the peer-reviewed online journal OBM Transplantation, stem cell biotechnology company Asymmetrex has now published a report describing how its technology for determining the specific dosage of therapeutic tissue stem cells works. The new technology is poised to revolutionize stem cell science and stem cell medicine by giving the

Asymmetrex Announces Plans to Provide Free Tissue Stem Cell Counting

Asymmetrex Announces Plans to Provide Free Tissue Stem Cell Counting

Today, June 16, Massachusetts stem cell biotechnology company Asymmetrex announces that it will begin offering free tissue stem cell counting on its company website. Scheduled for opening July 5, Independence Day weekend in the U.S., the company’s counting site will give academic scientists, stem cell medicine physicians, tissue stem cell suppliers, and drug companies a